Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis - Top-Institutions - MDSpire

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

  • By

  • Philipp Berning

  • Markus Maulhardt

  • Hristo Boyadzhiev

  • Anca-Maria Albici

  • Snjezana Janjetovic

  • Anna Ossami Saidy

  • Christian Schultze-Florey

  • Simon Call

  • Friedrich Stölzel

  • Annamaria Brioli

  • Michael Daskalakis

  • Juliane Knust

  • Justin Hasenkamp

  • Rebecca Wurm-Kuczera

  • Alexander Pohlmann

  • Matthias Stelljes

  • Cyrus Khandanpour

  • Ulrike Bacher

  • Amelie Boquoi

  • Florian H. Heidel

  • Hans Christian Reinhardt

  • Gerald Wulf

  • Natalie Schub

  • Bastian von Tresckow

  • Georg Lenz

  • Thomas Pabst

  • Evgenii Shumilov

  • June 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
    Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, Beijing

    Key Differentiators

    • Hematology

  • #2

    University Hospital Münster
    University Hospital Münster

    Münster, North Rhine-Westphalia

    Key Differentiators

    • Hematology

  • #3

    National Cancer Institute’s Center for Cancer Research
    National Cancer Institute’s Center for Cancer Research

    Bethesda, Maryland

    Key Differentiators

    • Hematology

Original Source(s)

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

  • by Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca-Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian Schultze-Florey, Simon Call, Friedrich Stölzel, Annamaria Brioli, Michael Daskalakis, Juliane Knust, Justin Hasenkamp, Rebecca Wurm-Kuczera, Alexander Pohlmann, Matthias Stelljes, Cyrus Khandanpour, Ulrike Bacher, Amelie Boquoi, Florian H. Heidel, Hans Christian Reinhardt, Gerald Wulf, Natalie Schub, Bastian von Tresckow, Georg Lenz, Thomas Pabst, Evgenii Shumilov

  • June 2, 2026

Related Content

Sustained complete response to TMEp-CI-M platform in refractory small-cell lung cancer with brainstem metastasis: a case report with over 20 months of disease-free survival

Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential

Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection